semaglutide arrhythmia and the Heart: Focus on Their Love–Hate Relationship Comparative Cardiovascular Pharmacovigilance of Semaglutide

2022;119:e2204527119

Mice were treated with a dose injection at 9 am on day 23 and euthanized 2 hours later for tissue collection

But, before starting any new type of exercise, please consult with your physician first

No medication permanently resets your appetite set point

Research Summary Dihexa is a small peptide angiotensin IV derivative shown in preclinical studies primarily using rodent models to significantly enhance synaptogenesis, cognitive function, and neuroprotection by activating the HGF/c-Met pathway

Dihexa demonstrates promising potential for treating neurodegenerative conditions like Alzheimers and Parkinsons disease through its ability to form new functional synapses